Figure 2From: Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?Distribution of ypT stage in 153 patients treated with preoperative RCT within clinical phase II/III trials. 107 patients (70%) manifested as intermediate responders with irradiation-induced tumor regression (TRG 2/3)[17] and ypT2 and ypT3 category.Back to article page